AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 19 filers reported holding AEGERION PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,217,000 | +1.4% | 1,500,000 | 0.0% | 0.16% | +2.5% |
| Q1 2017 | $1,200,000 | +12.3% | 1,500,000 | 0.0% | 0.16% | +11.9% |
| Q4 2016 | $1,069,000 | +14.1% | 1,500,000 | 0.0% | 0.14% | 0.0% |
| Q3 2016 | $937,000 | +9.6% | 1,500,000 | 0.0% | 0.14% | -3.4% |
| Q2 2016 | $855,000 | +12.2% | 1,500,000 | 0.0% | 0.15% | +12.1% |
| Q1 2016 | $762,000 | -23.5% | 1,500,000 | 0.0% | 0.13% | -38.6% |
| Q4 2015 | $996,000 | -11.2% | 1,500,000 | 0.0% | 0.22% | -46.4% |
| Q3 2015 | $1,121,000 | – | 1,500,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |